Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions.

This podcast is provided by pharmacists and faculty members at Rosal Franklin University College of Pharmacy.

This podcast contains general information for educational purposes only. This is not

professional advice and should not be used in lieu of obtaining advice from a qualified health

care provider. And now on to the show. Welcome to Helix Talk episode 61. I'm your

co-coons, Dr. Kane. I'm Dr. Schumann. And I'm Dr. Patel. And so today I know we're going to shift years and talk about an issue that I'm really noticing a trend

toward hitting the forefrontly and something I've been really passionate about.

And that's going to be a chronic pain management or in this case correcting the course,

careful opioid prescribing.

This really deals with the idea that over the past decades we've had

an issue in the U.S. about opioid prescribing and patients becoming addicted to prescription medications

and non-patients abusing those prescription medications, hence why, you know, hydrocodone,

acetaminophen combination products have now made it to the C2 DEA schedule

where they used to be C3s, things like that.

Yeah, and then I think we knew about the issues, maybe like in a pocket-by-pocket side,

but then CDC took the lead and say, we're going to spend a lot of time talking about some of the recommendation that came

through the CDC in 2014.

Right.

So a brief background is that this is some of this idea about chronic pain, is what the

main piece of it is.

And that's something that based upon data we found that anywhere between, you know,

or 11% of individuals in the U.S. have a daily pain and then based upon data we found that anywhere between, you know, or 11% of individuals in the U.S.

...